Robert D. Schwab

Hematology
3400 Spruce St
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development.

OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development.

Journal: Circulation
Published: November 21, 2025

Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

Journal: Cancer research
Published: October 21, 2025

Advances in cancer immunotherapies.

Advances in cancer immunotherapies.

Journal: Cell
Published: April 14, 2023

Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?

Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?

Journal: Current treatment options in oncology
Published: March 19, 2023

Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature.

Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature.

Journal: Blood advances
Published: February 03, 2023

Protamine loops DNA in multiple steps.

Protamine loops DNA in multiple steps.

Journal: Nucleic acids research
Published: December 10, 2019

Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies.

Approaches of T Cell Activation and Differentiation for CAR-T Cell Therapies.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 11, 2019

Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.

Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.

Journal: Journal of neuro-oncology
Published: September 16, 2018

Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.

Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.

Journal: Seminars in oncology
Published: April 05, 2016

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

Journal: Immunity
Published: August 12, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026